Michael Zinda
Chief Tech/Sci/R&D Officer chez REPARE THERAPEUTICS INC.
Fortune : 338 687 $ au 31/03/2024
Profil
Michael Zinda is currently the Chief Scientific Officer & Executive VP at Repare Therapeutics, Inc. He previously worked at AstraZeneca PLC as the Executive Director & Head-Cancer Bioscience from 2001 to 2017, and at Repare Therapeutics USA, Inc. as the Executive VP, Head-Research & Development from 2017 to 2019.
Dr. Zinda holds a doctorate degree from Vanderbilt University and an undergraduate degree from Minnesota State University Moorhead.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0,17% | 01/04/2024 | 71 908 ( 0,17% ) | 338 687 $ | 31/03/2024 |
Postes actifs de Michael Zinda
| Sociétés | Poste | Début |
|---|---|---|
| REPARE THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
Anciens postes connus de Michael Zinda
| Sociétés | Poste | Fin |
|---|---|---|
| Repare Therapeutics USA, Inc. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
| ASTRAZENECA PLC | Director/Board Member | 01/05/2017 |
Formation de Michael Zinda
| Vanderbilt University | Doctorate Degree |
| Minnesota State University Moorhead | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
| Repare Therapeutics USA, Inc. |
